Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.
Mehmet BerközFerbal Özkan-YılmazArzu Özlüer-HuntMirosław KrośniakÖmer TürkmenDuygu KorkmazSıddık KeskinPublished in: Pharmacological reports : PR (2021)
The results obtained from this study demonstrated that the anticancer activity of artesunate occurred via STAT3 pathway and its target proteins. Therefore, it can be suggested that artesunate may be an important candidate molecule in the treatment of melanoma.